ClinicalTrials.Veeva

Menu

Effect of Transfusion of Plasma on Endothelial During Liver Transplantation

Capital Medical University logo

Capital Medical University

Status

Enrolling

Conditions

Liver Transplantation
End Stage Liver DIsease

Treatments

Diagnostic Test: blood sample
Biological: fresh frozen plasma

Study type

Interventional

Funder types

Other

Identifiers

NCT04107883
LX-2019-LT-1

Details and patient eligibility

About

To study the effects of plasma transfusionon during liver transplantation on endothelial condition and short-term outcome in patients with end-stage liver disease.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Child A/B cirrhosis
  • patients who undergo the first OLT
  • Informed and consented
  • complete follow-up
  • cooperate with treatment

Exclusion criteria

  • re-transplant
  • combined liver and other organ transplantation
  • BMI≥30Kg/m2
  • patients with hypertension, diabetes, coronary heart disease, chronic renal insufficiency, preoperative pulmonary infection, pleural effusion
  • acute liver failure

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

control group
Experimental group
Description:
perform artificial colloidal solution transfusion during anhapetic phase.
Treatment:
Diagnostic Test: blood sample
anhapetic group
Experimental group
Description:
Perform plasma transfusion during anhapetic phase.
Treatment:
Biological: fresh frozen plasma
Diagnostic Test: blood sample

Trial contacts and locations

1

Loading...

Central trial contact

Xun Liu; Anshi Wu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems